𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of Mucopolysaccharidosis Type VI Mutations in Siamese Cats

✍ Scribed by A.C. Crawley; F.H. Muntz; M.E. Haskins; B.R. Jones; J.J. Hopwood

Book ID
118093981
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
29 KB
Volume
17
Category
Article
ISSN
0891-6640

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mutational analysis of 105 mucopolysacch
Mutational analysis of 105 mucopolysaccharidosis type VI patients
✍ Litsa Karageorgos; Doug A. Brooks; Anthony Pollard; Elizabeth L. Melville; Leann πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 294 KB πŸ‘ 1 views

## Communicated by William Sly Mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy syndrome) is a lysosomal storage disorder caused by mutations in the N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ARSB) gene. ARSB is a lysosomal enzyme involved in the degradation of the glycosaminoglycans

Mucopolysaccharidosis type VI: Structura
Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase
✍ Tom Litjens; John J. Hopwood πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 401 KB πŸ‘ 1 views

## Mucopolysaccharidosis type VI (MPS-VI ) is an autosomal recessive lysosomal storage disorder caused by the deficiency of N-acetylgalactosamine-4-sulfatase (4S; or ARSB). Mutations in the 4S gene are responsible for 4S deficiency, which leads to the intralysosomal storage of partially degraded g

Analysis of five mutations in 20 mucopol
Analysis of five mutations in 20 mucopolysaccharidosis type I patients: High prevalence of the W402X mutation
✍ Laura Gort; Amparo ChabΓ‘s; M. Josep Coll πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 27 KB πŸ‘ 1 views

Mucopolysaccharidosis type I is a lysosomal storage disease due to a-L-Iduronidase deficiency. Three main phenotypes have been reported: Hurler (severe), Scheie (mild) and Hurler/Scheie (intermediate). High prevalence of mutations W402X and Q70X has been described. We studied these two mutations in

Mutational analysis of mucopolysaccharid
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy
✍ L. Karageorgos; P. Harmatz; J. Simon; A. Pollard; P. R. Clements; D. A. Brooks; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 121 KB πŸ‘ 1 views

## Communicated by Andreas Gal Mucopolysaccharidosis type VI (MPS VI), or Maroteaux-Lamy syndrome, is a lysosomal storage disorder caused by a deficiency of N-acetylgalactosamine-4-sulfatase (ARSB). Seven MPS VI patients were chosen for the initial clinical trial of enzyme replacement therapy. Dir